ADC Therapeutics
ADCT
ADCT
58 hedge funds and large institutions have $273M invested in ADC Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.46% more ownership
Funds ownership: 44.43% → 44.88% (+0.46%)
46% less capital invested
Capital invested by funds: $501M → $273M (-$229M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
58
Holding in Top 10
1
Calls
$198K
Puts
$117K
Top Buyers
| 1 | +$5.09M | |
| 2 | +$1.29M | |
| 3 | +$1.11M | |
| 4 |
Morgan Stanley
New York
|
+$951K |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$802K |
Top Sellers
| 1 | -$3.99M | |
| 2 | -$3.93M | |
| 3 | -$756K | |
| 4 |
VEA
Virtus ETF Advisers
New York
|
-$282K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$264K |